Trial intelligence / Profile preview

Different bupivacaine concentrations in erector spinae plane block during hepatic tumor ablation

PACTR202109777479068Recruiting

Sponsor
Mansoura University
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Trial of bupivacaine in hepatic neoplasm (2 arms), sponsored by Mansoura University. Primary endpoint: Post-procedural pain. Started Sep 2021; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

hepatic neoplasm

Beyond the preview

Go deeper on PACTR202109777479068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202109777479068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call